Orphazyme A/S (OZYMF)
USD 90.0
(0.0%)
USD 90.0
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | - DKK | 0.0% |
| 2022 | - USD | -100.0% |
| 2021 | 379.33 Thousand DKK | -90.32% |
| 2020 | 3.91 Million DKK | -49.47% |
| 2019 | 7.75 Million DKK | 0.0% |
| 2018 | - DKK | 0.0% |
| 2017 | - DKK | 0.0% |
| 2016 | - DKK | 0.0% |
| 2015 | - DKK | 0.0% |
| 2014 | - DKK | 0.0% |
| 2013 | - DKK | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | - USD | 0.0% |
| 2023 Q1 | - DKK | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2023 Q3 | - DKK | 0.0% |
| 2023 Q4 | - USD | 0.0% |
| 2023 FY | - DKK | 0.0% |
| 2022 Q2 | - DKK | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2022 FY | - USD | -100.0% |
| 2022 Q1 | - DKK | -100.0% |
| 2022 Q3 | - DKK | 0.0% |
| 2021 Q1 | 22.6 Million DKK | -32.94% |
| 2021 Q2 | 22.6 Million DKK | 0.0% |
| 2021 Q3 | 6.4 Million DKK | -71.66% |
| 2021 Q4 | 6.4 Million DKK | 0.0% |
| 2021 FY | 379.33 Thousand DKK | -90.32% |
| 2020 Q1 | 47.8 Million DKK | -22.17% |
| 2020 FY | 3.91 Million DKK | -49.47% |
| 2020 Q4 | 33.7 Million DKK | 0.0% |
| 2020 Q2 | 47.8 Million DKK | 0.0% |
| 2020 Q3 | 33.7 Million DKK | -29.49% |
| 2019 Q3 | 61.41 Million DKK | 543.74% |
| 2019 Q4 | 61.41 Million DKK | 0.0% |
| 2019 Q1 | 9.54 Million DKK | 0.0% |
| 2019 Q2 | 9.54 Million DKK | 0.0% |
| 2019 FY | 7.75 Million DKK | 0.0% |
| 2018 Q4 | - DKK | 0.0% |
| 2018 FY | - DKK | 0.0% |
| 2018 Q2 | - DKK | 0.0% |
| 2018 Q1 | - DKK | 0.0% |
| 2018 Q3 | - DKK | 0.0% |
| 2017 Q3 | - DKK | 0.0% |
| 2017 FY | - DKK | 0.0% |
| 2017 Q2 | - DKK | 0.0% |
| 2017 Q1 | - DKK | 0.0% |
| 2017 Q4 | - DKK | 0.0% |
| 2016 Q3 | - DKK | 0.0% |
| 2016 Q4 | - DKK | 0.0% |
| 2016 Q1 | - DKK | 0.0% |
| 2016 FY | - DKK | 0.0% |
| 2015 FY | - DKK | 0.0% |
| 2014 FY | - DKK | 0.0% |
| 2013 FY | - DKK | 0.0% |